Nektar Therapeutics
Open
70.93 8.66
Overview
Share price change
24h
Min
64.81
Max
71.41
Income | -8.8M -45M |
|---|---|
Sales | -11M 11M |
EPS | -1.82 |
Profit margin | -413.443 |
Employees | 63 |
EBITDA | -18M -37M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +136.01% upside |
Next Earnings | 6 sie 2026 |
|---|
Market Cap | -712M 2.2B |
|---|---|
Previous open | 62.27 |
Previous close | 70.93 |
Nektar Therapeutics Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Nektar Therapeutics Forecast
Price Target
By TipRanks
136.01% upside
12 Months Forecast
Average 154.33 USD 136.01%
High 192 USD
Low 80 USD
Based on 8 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$